Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
CARDIMET MR 35MG Tablet is indicated for:-
Long-term management of angina pectoris.
-
Enhancing cardiac efficiency in ischemic conditions.
-
Reducing episodes of chest pain in coronary artery disease.
-
Pharmacology:
CARDIMET contains trimetazidine, which improves myocardial energy metabolism by inhibiting fatty acid oxidation and promoting glucose utilization. This reduces ischemic damage and enhances cardiac efficiency.
Dosage and Administration:
-
Recommended Dose: 35 mg twice daily, preferably during meals.
-
Adjust dosage based on clinical response and as directed by a physician.
-
Not recommended for children or patients with severe renal impairment.
Interaction:
-
Minimal drug interaction risk.
-
Use cautiously with other anti-anginal medications for additive effects.
Contraindications:
-
Hypersensitivity to trimetazidine or any component of the formulation.
-
Patients with severe renal impairment.
-
Not suitable for individuals with movement disorders such as Parkinson’s disease.
Side Effects:
-
Common: Dizziness, headache, gastrointestinal discomfort.
-
Rare: Allergic skin reactions, extrapyramidal symptoms, or severe drowsiness.
Pregnancy & Lactation:
-
Use only if clearly needed during pregnancy; insufficient data on safety.
-
Avoid during breastfeeding as data on excretion into breast milk is limited.
Precautions & Warnings:
-
Monitor for any signs of movement disorders or extrapyramidal symptoms.
-
Not suitable for acute angina episodes or as a first-line therapy for unstable angina or myocardial infarction.
-
Use cautiously in elderly patients with renal impairment.
Therapeutic Class:
Anti-ischemic agents.
Storage Conditions:
Store below 30°C, away from direct light and moisture. Keep out of reach of children
.jpeg)
 10P.jpg)
.jpg)
 100ML.jpg)
.jpg)
Change Language